Filing Details

Accession Number:
0000914190-13-000338
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-16 17:15:52
Reporting Period:
2013-05-14
Filing Date:
2013-05-16
Accepted Time:
2013-05-16 17:15:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198920 D Glen Nelson 651 Campus Drive
St. Paul MN 55112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-14 1,753 $18.91 418,338 No 4 P Direct
Common Stock Acquisiton 2013-05-15 100 $19.00 418,438 No 4 P Direct
Common Stock Acquisiton 2013-05-16 2,900 $18.94 421,338 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 28,500 Indirect By Family Trust
Common Stock 258,655 Indirect Held by LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $12.37 2015-11-30 9,705 9,705 Direct
Common Stock Stock Option (right to buy) $9.28 2014-11-30 6,470 6,470 Direct
Common Stock Stock Option (right to buy) $8.83 2016-12-18 12,940 12,940 Direct
Common Stock Stock Option (right to buy) $7.90 2017-10-08 4,322 4,322 Direct
Common Stock Stock Option (right to buy) $11.38 2017-11-12 15,087 15,087 Direct
Common Stock Warrant $9.28 2008-09-12 2013-09-12 53,916 53,916 Indirect
Common Stock Warrant $8.83 2009-02-25 2014-02-24 56,558 56,558 Indirect
Common Stock Warrant (right to buy) $9.28 2010-11-30 2013-09-12 117,399 117,399 Indirect
Common Stock Warrant (right to buy) $8.83 2010-11-30 2014-02-24 452,729 452,729 Indirect
Common Stock Restricted Stock Units $0.00 5,714 5,714 Direct
Common Stock Restricted Stock Units $0.00 11,628 11,628 Direct
Common Stock Restricted Stock Units $0.00 21,739 21,739 Direct
Common Stock Restricted Stock Units $0.00 7,192 7,192 Direct
Common Stock Restricted Stock Units $0.00 10,917 10,917 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-11-30 9,705 9,705 Direct
2014-11-30 6,470 6,470 Direct
2016-12-18 12,940 12,940 Direct
2017-10-08 4,322 4,322 Direct
2017-11-12 15,087 15,087 Direct
2013-09-12 53,916 53,916 Indirect
2014-02-24 56,558 56,558 Indirect
2013-09-12 117,399 117,399 Indirect
2014-02-24 452,729 452,729 Indirect
5,714 5,714 Direct
11,628 11,628 Direct
21,739 21,739 Direct
7,192 7,192 Direct
10,917 10,917 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $18.92 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.87 to $19.00 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Shares are held by the Glen D. Nelson 2012 Family Trust for the benefit of Dr. Nelson's wife and descendants.
  4. Shares are held by GDN Holdings, LLC, of which Dr. Nelson is the sole owner.
  5. Fully exercisable.
  6. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and will be payable in cash or shares of the Company's Common Stock beginning six months following the termination of the reporting person's board membership.
  7. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and will be payable in cash or shares of the Company's common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 2,730 on each of 9/30/2012, and 2,729 on 12/31/2012, 3/31/2013, and 6/30/2013.